Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue-Based Products

Robert P Dickson; Deborah A Dingell

doi:10.1001/jama.2024.6834

Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue-Based Products

JAMA. 2024 May 28;331(20):1703-1704. doi: 10.1001/jama.2024.6834.

Authors

Robert P Dickson^{1

2}, Deborah A Dingell³

Affiliations

¹ Washtenaw County Tuberculosis Program, Ypsilanti, Michigan.
² University of Michigan Medical School, Ann Arbor.
³ US House of Representatives, Washington, DC.

PMID: 38696201
DOI: 10.1001/jama.2024.6834

No abstract available

Plain language summary

This Viewpoint discusses the death of a patient caused by unregulated biological products and efforts to encourage federal government oversight of such products.

MeSH terms

Cell- and Tissue-Based Therapy
Government Regulation*
Humans
Tissue Banks / legislation & jurisprudence
United States
United States Food and Drug Administration*